Note: Descriptions are shown in the official language in which they were submitted.
CA 02261186 1999-02-19
EXPRESSION AND SECRETION OF HETEROLOGOUS POLYPEPTIDES
FROM FRESHVAATER CAULOBACTER
Field of Invention
This invention relates to the expression and secretion
of heterologous peptides, from Caulobacter wherein the
heterologous polypeptide is fused with the surface layer
protein (S-layer protein) of the bacterium, or a portion of
the S-layer protein.
Background of the Invention
Many genera of bacteria assemble layers composed of
repetitive, regularly aligned, proteinaceous sub-units on
the outer surface of the cell. These layers are
essentially two-dimensional paracrystalline arrays, and
being the outer molecular layer of the organism, directly
interface with the environment. Such layers are commonly
known as S-layers and are found on members of every
taxonomic group of walled bacteria including:
Archaebacteria; Chlamydia; Cyanobacteria; Acinetobacter;
Bacillus; Aquaspirillum; Caulobacter; Clostridium;
Chromatium. Typically, an S-layer will be composed of an
intricate, geometric array of at least one major protein
having a repetitive regular structure. In many cases, such
as in Caulobacter, the S-layer protein is synthesized by
the cell in large quantities and the S-layer completely
envelopes the cell and thus appears to be a protective
layer.
Caulobacter are natural inhabitants of most soil and
freshwater environments and may persist in waste water
treatment systems and effluents. The bacteria alternate
between a stalked cell that is attached to a surface, and
an adhesive motile dispersal cell that searches to find a
new surface upon which to stick and convert to a stalked
cell. The bacteria attach tenaciously to nearly all
surfaces and do so without producing the extracelluar
CA 02261186 1999-02-19
- 2 -
enzymes or polysaccharide "slimes" that are characteristic
of most other surface attached bacteria. They have simple
requirements for growth. The organism is ubiquitous in the
environment and has been isolated from oligotrophic to
mesotrophic situations. Caulobacters are known for their
ability to tolerate low nutrient level stresses, for
example, low phosphate levels. This nutrient can be
limiting in many leachate waste streams, especially those
with high levels of iron or calcium.
All of the freshwater Caulobacter that produce an
S-layer are similar and have S-layers that are
substantially the same. Such S-layers appear similar by
electron microscopy with the layer being hexagonally
arranged in all cases with a similar centre-centre
dimension (see: Walker, S.G., et al. (1992). "Isolation
and Comparison of the Paracrystalline Surface Layer
Proteins of Freshwater Caulobacters" J. Bacteriol. 174:
1783-1792). 16S rRNA sequence analysis of several S-layer
producing Caulobacter strains suggest that they group
closely (see: Stahl, D.A. et al. (1992) "The Phylogeny of
Marine and Freshwater Caulobacters Reflects Their Habitat"
J. Bacteriol. 174:2193-2198). DNA probing of Southern
blots using the S-layer gene from C. crescentus CB15
identifies a single band that is consistent with the
presence of a cognate gene (see: MacRae, J.D. and, J. Smit.
(1991) "Characterization of Caulobacters Isolated from
Wastewater Treatment Systems" Applied and Environmental
Microbiology 57:751-758). Furthermore, antisera raised
against the S-layer protein of C. crescentus strain CB15
reacts with S-layer proteins from other Caulobacter (see:
Walker, S.G. et al. (1992) [supra]). All S-layer proteins
isolated from Caulobacter may be substantially purified
using the same extraction method (pH extraction) which
would not be expected to be a general purpose method for
other bacterial membrane or surface associated proteins.
All strains appear to have a polysaccharide reactive with
CA 02261186 1999-02-19
- 3 -
antisera reactive against CB15 lipopolysaccharide species
which appears to be required for S-layer attachment (see:
Walker, S.G. et al. (1992) [supra] ) .
Freshwater Caulobacter producing S-layers may be
readily detected by negative stain transmission electron
microscopy techniques. Caulobacter may be isolated using
the methods outlined by MacRae, J.D. and Smit (1991)
[su ra], which take advantage of the fact that Caulobacter
can tolerate periods of starvation while other soil and
water bacteria may not and that they all produce a
distinctive stalk structure, visible by light microscopy
(using either phase contrast or standard dye staining
methods). Once Caulobacter strains are isolated in a
typical procedure, colonies are suspended in 2% ammonium
molybdate negative stain and applied to plastic-filmed,
carbon-stabilized 300 or 400 mesh copper or nickel grids
and examined in a transmission electron microscope at 60
kilovolt accelerating voltage (see: Smit, J. (1986)
"Protein Surface Layers of Bacteria", in Outer Membranes as
Model System, (M. Inouge, Ed. J. Wiley & Sons, at
page 343-376). S-layers are seen a two-dimensional
geometric patterns most readily on those cells in a colony
that have lysed and released their internal contents.
Isolation and characterization of numerous freshwater
Caulobacter species and strains of species have been
described, including suitable methods in: MacRae, J.D. and
J. Smit (1991) [supra] and in Walker, S.G. et al. (1992)
[supra] .
The S-layer elaborated by freshwater isolates of
Caulobacter are visibly indistinguishable from the S-layer
produced by Caulobacter crescentus strains CB2 and CB15.
The S-layer proteins from the latter strains have
approximately 100,000 m.w. although sizes of S-layer
proteins from other species and strains will vary. The
CA 02261186 1999-02-19
- 4 -
protein has been characterized both structurally and
chemically. It is composed of ring-like structures spaced
at 22nm intervals arranged in a hexagonal manner on the
outer membrane. The S-layer is bound to the bacterial
surface and may be removed by low pH treatment or by
treatment with a calcium chelator such as EDTA.
The similarity of S-layer proteins in different
strains of Caulobacter permits the use of a cloned S-layer
protein gene of one Caulobacter strain for retrieval of the
corresponding gene in other Caulobacter strains (see:
Walker, S.G. et al. (1992) [supra]; and, MacRae, J.D.
et al. (1991) [supra] .
Expression, secretion and optionally, presentation, of
a heterologous polypeptide as a fusion product with the
S-layer protein of Caulobacter provides advantages not
previously seen in systems using organisms such as E. coli
and Salmonella where fusion products of other kinds of
surface proteins have been expressed. All known
Caulobacter strains are believed to be harmless and are
nearly ubiquitous in aquatic environments. In contrast,
many Salmonella and E. coli strains are pathogens.
Consequently, expression and secretion of a heterologous
polypeptide using Caulobacter as a vehicle will have the
advantage that the expression system will be stable in a
variety of outdoor environments and may not present
problems associated with the use of a pathogenic organism.
Furthermore, Caulobacter are natural biofilm forming
species and may be adapted for use in fixed biofilm
bioreactors. The quantity of S-layer protein that is
synthesized and is secreted by Caulobacter is high,
reaching 12% of the cell protein. The unique
characteristics of the repetitive, two-dimensional S-layer
would also make such bacteria ideal for use as an
expression system, or as a presentation surface for
heterologous polypeptides. This is desirable in a live
CA 02261186 1999-02-19
- 5 -
vaccine to maximize presentation of the antigen or
antigenic epitope. In addition, use of such a presentation
surface to achieve maximal exposure of a desired
po:lypeptide to the environment results in such bacteria
being particularly suited for use in bioreactors or as
carriers for the polypeptide in aqueous or terrestrial
outdoor environments.
The invention described in the PCT application
published September 18, 1997 under WO 97/34000 pertains to
the discovery that the C-terminal region of Caulobacter
crescentus S-layer protein is essential for secretion of
that S-layer protein. That invention provided a DNA
construct comprising DNA encoding a heterologous
polypeptide sequence not present in the S-layer protein
upstream from and in-frame with DNA encoding at least the
82 C-terminal amino acids of the Caulobacter crescentus
S-layer protein. Conservation of the C-terminal region
among strains of C. crescentus was reported to be high.
Summary of Invention
This invention is based on the demonstration that
freshwater Caulobacter species other then C. crescentus
which produce an S-layer also rely on a secretion signal
located at the C-terminus of the S-layer protein. Sequence
information from diverse species of freshwater Caulobacter
shows a high degree of homology in downstream transporter
genes which encode proteins required for secretion of the
S-layer protein from the cell. A S-layer protein secretion
signal from a first species of Caulobacter will be
recognized by the transport mechanism of other species.
Thus, a C-terminal secretion signal derived from any
freshwater S-layer producing Caulobacter may be used in the
invention described in WO 97/34000, and any such
Caulobacter may be used as means for expression and
secretion of heterologous polypeptides not found in the
CA 02261186 1999-02-19
- 6 -
S-layer protein. For example, constructs for expression of
such heterologous polypeptides may employ a C-terminal
secretion signal of a freshwater Caulobacter other than
C. crescentus for expression in the same, species from
which the secretion signal was derived or for expression in
a different species. Furthermore, a C-terminal secretion
signal derived from the S-layer protein (RsaA) of
C. crescentus may be used in such transformation of
Caulobacter other than C. crescentus.
This invention provides a DNA construct comprising one
or more restriction sites for facilitating insertion of DNA
into the construct, wherein the construct further comprises
DNA encoding a C-terminal secretion signal of a Caulobacter
S-layer protein other than the C-terminal secretion signal
of the S-layer protein of C. crescentus.
This invention also provides a DNA construct
comprising DNA encoding a polypeptide not present in
Caulobacter S-layer protein upstream from and in-frame with
DNA encoding a C-terminal secretion signal of a Caulobacter
S-layer protein other than C. crescentus.
This invention also provides a bacterial cell
comprising the aforementioned DNA constructs. Where the
bacterial cell is other than C. crescentus, the DNA
construct may comprise a C-terminal secretion signal
derived from RsaA. This invention also provides the use of
the aforementioned DNA constructs for transformation of
bacterial cells and the use of such cells for expression
and secretion of polypeptides heterologous to the cell.
Where the cell is Caulobacter, the polypeptide is
heterologous to the S-layer protein of the cell.
CA 02261186 1999-02-19
Description of the Drawinas
For better understanding of this invention, reference
may be made to the preferred embodiments and examples
described below, and the accompanying drawing in which:
Figure 1 (comprising Figures la, lb, and lc) shows the
complete nucleotide sequence of the C. crescentus S-layer
(rsaA) gene (SEQ ID NO:1) and the predicted translational
product (SEQ ID N0:2) in the single letter amino acid code.
The -35 and -10 sites of the promoter region as well as the
start of transcription and the Shine-Dalgarno sequence are
indicated. Partial amino acid sequences determined by
Edman degradation of rsaA protein and of sequenced peptides
obtained after cleavage with V8 protease are indicated by
contiguous underlining. The putative transcription
terminator palindrome is indicated with arrowed lines. The
region encoding the glycine-aspartate repeats is indicated
by underlined amino acid code letters. This region
includes five aspartic acids that may be involved in the
binding of calcium ions.
Description of the Preferred Embodiments
Organisms for use in this invention are any S-layer
producing freshwater species or strains of Caulobacter.
While similarity of the S-layer gene and S-layer secretion
systems permits the use of any S-layer protein producing
freshwater Caulobacter in this invention, the C-terminal
secretion signals of the S-layer genes of C. crescentus
strains CB2 and CB15 (and variants of those strains which
contain homologs of the gene encoding the 1026 amino acid
paracrystalline S-layer protein described in: Gilchrist, A.
et al. 1992. "Nucleotide Sequence Analysis Of The Gene
Encoding the Caulobacter crescentus Paracrystalline Surface
Layer Protein". Can. J. Microbiol. 38:193-208) are often
CA 02261186 1999-02-19
_ g _
referred to in the detailed description and Examples set
out below.
Caulobacter strains which are incapable of forming an
S-:layer, including those which shed the S-layer protein
upon secretion, may be used in this invention. Examples
are the S-layer negative mutants CB2A and CB15AKSac
described in Smit, J., and N. Agabian. 1984. "Cloning of
the Major Protein of the Caulobacter crescentus Periodic
Surface Layer: Detection and Other Characterization of the
Cloned Peptide by Protein Expression Assays". J. Bacteriol.
160:1137-1145.; and, Edwards, P., and J. Smit. 1991. "A
Transducing Bacteriophage for Caulobacter crescentus Uses
the Paracrystalline Surface Layer Protein as Receptor".
J. Bacteriol. 173, 5568-5572. Examples of shedding strains
are CB15Ca5 and CB15Ca10 described in Edwards and Smit
(1991) [su ra], and the smooth lipopolysaccharide deficient
mutants described in Walker, S.G. et al. 1994.
"Characterization of Mutants of Caulobacter crescentus
Defective in Surface Attachment of the Paracrystalline
Surface Layer". J. Bacteriol. 176:6312-6323.
A heterologous polypeptide referred to herein may be
any peptide, polypeptide, protein or a part of a protein
which is desired to be expressed in Caulobacter and which
may be secreted by the bacterium. The heterologous
polypeptide includes enzymes and other functional sequences
of amino acids as well as ligands, antigens, antigenic
epitopes and haptens. The size of the heterologous
polypeptide will be selected depending upon whether an
intact S-layer is to be produced in the Caulobacter or
whether the chimeric protein to be recovered from the
bacterial medium as described below. Heterologous
polypeptides of about 400 amino acids have been expressed.
Preferably, the cysteine content of the heterologous
polypeptide and the capacity for formation of disulphide
bonds within the chimeric protein will be kept to a minimum
CA 02261186 1999-02-19
- 9 -
to minimize disruption of the secretion of the chimeric
protein. However, the presence of cysteine residues
capable of forming a disulphide bond which are relatively
close together, may not affect secretion.
This invention may be practised by implementing one or
more known methods to insert a selected heterologous coding
sequence into all or part of the S-layer protein gene so
that both the S-layer protein and the heterologous sequence
are transcribed "in-frame". Knowledge of an S-layer
protein gene sequence permits one to identify potential
sites to install the heterologous genetic material. The
repetitive nature of the protein in the S-layer permits
multiple copies of a heterologous polypeptide to be
presented on the surface of the cell.
The following general procedure lays out courses of
action and specifies particular plasmid vectors or
constructions that may be used to accomplish fusion of an
S-:Layer protein with a polypeptide of interest. The
following description uses the rsaA (S-layer) gene of
C. crescentus as an example (see Figure 1 and SEQ ID NO: l).
The latter gene sequence is characterized in
Gilchrist, A. et al. (1992) [supra).
The general procedure includes detailed steps allowing
for the following possibilities:
(1) use of a collection of potentially permissive
sites in the S-layer gene to install the genetic
information for a polypeptide of interest;
(2) use of a Carrier cassette for delivering a gene
of interest to sites within the S-layer gene (the cassette
offers several advantages over direct modification of a
gene of interest, in preparation for insertion);
CA 02261186 1999-02-19
- 10 -
(3) creation of a collection of random insertion
sites based on a restriction enzyme of choice, if the
available collection of potentially permissive sites is for
some reason unsuitable; and,
(4) preparation of DNA coding for a polypeptide of
interest for direct insertion into permissive sites
(i.e., not using the Carrier cassette) by a method best
suited for the particular case (several options are
suggested).
The general procedure involves the following steps and
alternative courses of action. As a first step the
practitioner will choose an appropriate region (or specific
amino acid position) of the S-layer for insertion of a
desired polypeptide. Second, the practitioner will create
a unique restriction site (preferably hexameric) in the
S-layer gene at a position within the gene encoding that
region (or corresponding to a specific amino acid) using
either standard linker mutagenesis (regional) or site
directed mutagenesis (specific amino acid). The unique
restriction site will act as a site for accepting DNA
encoding the polypeptide of interest. For example, the
plasmid-based promoter-less version of the rsaA gene
(pTZlBU: rsaA~P) shown may be used because it contains an
appropriate combination of 5' and 3' restriction sites
useful for subsequent steps (see: Gilchrist, A. et al.
(1992) [supra]). The restriction site should not occur in
the S-layer gene, its carrier plasmid or the DNA sequence
coding for the polypeptide of interest.
If it is unclear which region of the S-layer would be
suitable for insertion of a polypeptide of interest, a
random linker mutagenesis approach is used to randomly
insert a unique linker-encoded restriction site (preferably
hexameric) at various positions in the gene. Sites for
insertion of the linker are created using an endonuclease,
CA 02261186 1999-02-19
- 11 -
either of a sequence specific nature (e. g. tetrameric
recognition site restriction enzyme) or sequence
non-specific nature (e.g. Deoxyribonuclease I [DNase I]).
A particularly suitable method is the generalized
selectable linker mutagenesis approach based on any desired
restriction site of: Bingle, W.H., and J. Smit. 1991
"Linker Mutagenesis Using a Selectable Marker: A Method
for Tagging Specific Purpose Linkers With an Antibiotic-
Resistance Gene". Biotechniques 10: 150-152. Because
endonuclease digestion is carried out under partial
digestion conditions, a library of linker insertions at
different positions in the gene is created. Partial
digestion with different endonucleases can create potential
sites for insertion of a linker.
If restriction endonucleases are used to create sites
for subsequent insertion of a linker encoding a hexameric
restriction site, mutagenesis may also be done with a
mixture of 3 different linkers incorporating appropriate
spacer nucleotides in order to satisfy reading frame
considerations at a particular restriction site (only 1 of
the 3 linker insertions will be useful for subsequent
acceptance of DNA encoding the polypeptide of interest).
With DNase I, only one linker is needed, but again only 1
of 3 linker insertions may be useful for accepting DNA
encoding the polypeptide of interest depending on the
position of the DNase I cleavage with respect to the
3 bases of each amino acid codon.
Next, a linker tagged with a marker is used to insert
DNA of interest at a restriction site. For example, if
BamHI sites are appropriate as sites for the introduction
of DNA encoding a polypeptide of interest, BamHI linkers
tagged with a kanamycin-resistance gene for selectable
linker mutagenesis may be used. One such 12-by linker
carried in plasmid pUC1021K for use in rsaA was described
by Bingle and Smit (1991) [supra] . Two additional 15-by
CA 02261186 1999-02-19
- 12 -
linkers (pUC7165K and pTZ6571K) for creating 2 other
possible translation frames within the linker insert itself
are described in Figures 3 and 4 of WO 97/34000. As
outlined above, a mixture of all three such linkers is
preferably used for mutagenesis at sites.
Once a library composed of linker insertions encoding
desired hexameric restriction site at different positions
has been created, DNA encoding a polypeptide of interest is
inserted into the sites en masse. The library is digested
with the restriction enzyme specific for the
newly-introduced linker encoded restriction site and
ligated to a DNA fragment encoding the polypeptide of
interest and carrying the appropriate complementary
cohesive termini. DNA specifying the polypeptide of
interest can be prepared by a number of standard methods,
which may include oligonucleotide synthesis of 2
anti-complementary strands, polymerase chain reaction (PCR)
procedures, or addition of linkers whose termini are
compatible with the introduced sites in the target gene to
a suitably modified segment of DNA.
In order to facilitate the rapid recovery of genes
carrying newly inserted DNA at restriction sites encoding
the polypeptide of interest, a Carrier oligonucleotide may
be used. An example of the use of such a carrier is shown
in Figure 1 of WO 97/34000. That Carrier was designed to
accept DNA (including multiple copies and mixtures)
prepared by PCR or annealed synthesized oligonucleotides
and controls direction of insertion of the foreign segment
into a rsaA gene through use of a promoterless drug
resistance marker. The DNA of interest is first
directionally cloned, if possible, using the XhoI, StuI, or
SalI sites or non-directionally cloned using any one of the
sites in the same orientation as a promoterless
chloramphenicol resistance (CmR) gene. To do this the DNA
of interest must be provided with the appropriate termini
CA 02261186 1999-02-19
- 13 -
for cloning and spacer nucleotides for maintaining correct
reading frame within the cassette and should not contain a
BQ.lII site. For insertion into the BamHI linker library,
the DNA of interest is recovered as a BamHI fragment tagged
with a CmR gene. When ligated to the BamHI digested rsaA
linker library, only those colonies of the bacterium
(eg. E. coli) used for the gene modification steps that are
recovered will be those carrying insertions of the desired
DNA in the correct orientation, since the promoter on the
plasmid is 5' to rsaAOP and the CmR gene. This eliminates
screening for DNA introduction and increases the recovery
of useful clones by 100 0 (1 of 3 versus 1 of 6) . While
still manipulating the library as one unit, the CmR gene is
removed using BalII. The carrier oligonucleotide also
provides the opportunity to add DNA 5' or 3' to the DNA of
interest at SalI, XhoI or StuI sites providing the DNA of
interest does not contain any of these sites. This allows
some control over spacing between rsaA sequences and the
sequence of the DNA of interest.
Next, the genes carrying the DNA of interest in the
correct orientation is excised from the plasmid and is
transferred to a suitable vector providing a promoter
recognized by Caulobacter. Such vectors include pWB9 or
pW810 (as described in Bingle, W.H., and J. Smit. 1990).
"High Level Plasmid Expression Vectors for Caulobacter
crescentus Incorporating the Transcription and
Transcription-Translation Initiation Regions of the
Paracrystalline Surface Layer Protein Gene". Plasmid 24:
143-148) with EcoRI/SstI sites. The DNA of interest should
not contain the same restriction sites present in the
vector. This allows expression of the hybrids in S-layer
negative mutants of Caulobacter.
Those Caulobacter surviving transfer are examined for
chimeric protein secretion, S-layer assembly and
presentation of the new polypeptide activity, antigenicity,
CA 02261186 1999-02-19
- 14 -
etc. by methods specific to the needs of the investigator
or the capabilities of the inserted sequence. Many of the
sites created are "benign" as they have no effect on the
functional regions of the protein involved with export,
self assembly, etc. However, not every site that results
in an absence of functional disruption of the S-layer is
best for insertion of new activities. Some sites may not
be well exposed on the surface of the organism and other
sites may not tolerate insertion of much more DNA than the
linker sequence.
By selecting the site of insertion of the heterologous
material, it is possible to express heterologous
polypeptides of up to about 130 amino acids in a S-layer
chimeric protein which will assemble as an S-layer on the
cell surface. Single or multiple insertions of smaller
polypeptides (eg. 10-20 amino acids) at a wide range of the
permissive sites in the S-layer gene will permit S-layer
formation. Some sites, as reported herein, are sensitive
to even small insertions resulting in the chimeric protein
being released into the medium. Release may also be
deliberately effected by use of a shedding strain of
Caulobacter to express the chimeric protein or by physical
removal of the S-layer from whole cells.
Where S-layer formation is not required, this
invention permits the expression of quite large
polypeptides (eg. about 200 amino acids) as part of the
S-layer protein. Expressing a chimeric protein containing
a S-layer protein component having substantial deletions,
as described below, may increase the size of the
heterologous polypeptides that will be expressed and
secreted by Caulobacter.
The preceding methods describe insertion of linkers
in-frame into a promoterless version of the S-layer gene.
The sites that are introduced allow subsequent insertion of
CA 02261186 1999-02-19
- 15 -
foreign DNA in-frame into the full length gene. This
invention also includes the construction of chimeric
S-layer protein genes and the resulting production of
chimeric S-layer proteins wherein the S-layer gene
component is highly modified by deleting large portions of
that gene which reduces the amount of Caulobacter protein
present in the secreted chimeric protein.
Generally, large deletions throughout the S-layer gene
will result in a chimeric protein that is not capable of
forming an S-layer. Attachment of the S-layer to the cell
is abolished if the N-terminal amino acids which contribute
to S-layer formation are deleted. For example, deletion of
the f first 29 N-terminal amino acids of the C . crescentus
protein will accomplish this. In C. crescentus, deletion
of the first 776 amino acids from the N-terminal region
will still result in a chimeric protein that is secreted
from the cell but having a S-layer protein component of
only the 250 C-terminal amino acids. Since only the
extreme C-terminal region corresponding to approximately
amino acids 945-1026 of RsaA is required for secretion of
an S-layer chimeric protein from C. crescentus, use of only
the C-terminal secretion signal will prevent S-layer
formation. Furthermore, use of only the C-terminal region
of not only permits the cell to transport the chimeric
protein outside of the cell, but also promotes spontaneous
aggregation of much of the secreted chimeric protein in the
cell medium and formation of a macroscopic precipitate that
may be collected with a course mesh or sheared to
micron-sized particles which may be ideal for vaccine
presentation. Yields of up to 250 mg. (dry weight) of
protein per liter of cells may be possible.
Sequence analysis of the 3' region of the S-layer
genes from different strains of Caulobacter shows that the
portion of the gene encoding the C-terminal region of the
S-layer protein is highly conserved, as are the immediate
CA 02261186 1999-02-19
- 16 -
downstream non-translated and translated regions among
different strains and species. Sequence analysis of the
S-layer genes and downstream regions in CB15 and CB2A
(which are readily distinguishable strains) shows identical
DNA sequences coding for the last 118 C-terminal amino
acids of the S-layer protein and the downstream
non-translated region. Sequencing of the next downstream
translated gene to amino acid 97 of the gene product shows
only a single base pair change between CB15 and CB2A,
resulting in a conservative amino acid substitution in the
translation product. Conservation of the C-terminal region
of Caulobacter S-layer protein and associated coding
regions shows that this invention may be carried out using
any Caulobacter producing a S-layer protein.
It having been now demonstrated that species of
Caulobacter other than crescentus employ a C-terminal
secretion signal for the S-layer protein, the procedures
described herein may be employed to identify and use the
C-terminal secretion signal from Caulobacter other than
C. crescentus. The minimal size of the amino acid region
from the Caulobacter that constitutes the signal may be
determined by following description and the Examples
herein. One approach is to identify coding regions from
S-layer genes of Caulobacter which code for amino acid
sequences that exhibit homology to the last 82 C-terminal
residues of the RsaA protein of C. crescentus or, which
exhibit homology to the nucleotide sequence in rsaA which
encodes the aforementioned 82 amino acids. Homology to
upstream sequences in the C-terminal region may also be
assessed.
An amino acid or nucleic acid sequence is "homologous"
to another sequence if the two sequences are substantially
identical and the functional activity of the sequences is
conserved (for example, both sequences function as or
encode a secretion signal). Two amino acid or nucleic acid
CA 02261186 1999-02-19
- 17 -
sequences are considered substantially identical if they
share at least about 75o sequence identity, preferably at
least about 90% sequence identity, and more preferably at
least 95% sequence identity. Sequence identity may be
determined using the BLAST algorithm, described in Altschul
et al. (1990), J. Mol. Biol. 215:403-10 (using the
published default settings). In such circumstances,
percentage of sequence identity may be expressed as
"homology" of the same percentage.
An alternative indication that two nucleic acid
sequences are homologous (substantially identical) is when
two sequences hybridize to each other under moderately
stringent, or preferably stringent conditions.
Hybridization to filter-bound sequences under moderately
stringent conditions may, for example, be performed in
0.5 M NaHP04, 7% sodium dodecyl sulfate (SDS), 1 mM EDTA at
65°C, and washing in 0.2 x SSC/O.lo SDS at 42°C (see
Ausubel et al. (eds), 1989, Current Protocols in Molecular
Bioloay, Vol. 1, Green Publishing Associates, Inc., and
John Wiley & Sons, Inc., New York, at page 2,10.3).
Alternatively, hybridization to filter-bound sequences
under stringent conditions may, for example, be performed
in 0.5 M NaHP04, 7% SDS, 1 mM EDTA at 65°C, and washing in
0.1 x SSC/0.1% SDS at 68°C (see Ausubel, et al. (eds),
1989, [supra]). Hybridization conditions may be modified
in accordance with known methods depending on the sequence
of interest (see Tijssen, 1993, Laboratory Techniques in
Biochemistry and Molecular Biology - Hybridization with
Nucleic Acid Probes, Part I, Chapter 2 "Overview of
Principles of Hybridization and the Strategy of Nucleic
Acid Probe Assays", Elsevier, New York). Generally,
stringent conditions are selected to be about 5°C lower
than the thermal melting point for the specific sequence at
a defined ionic strength and pH.
CA 02261186 1999-02-19
- 18 -
This invention may be practised by expression of
modified S-layer genes borne on plasmids that are broad
host range vectors capable of being expressed in
Caulobacter. Such plasmids are readily constructed and
introduced to Caulobacter by electroportation. Typically,
the plasmid is maintained in the Caulobacter by antibiotic
selection. Highly modified S-layer genes with attached
heterologous sequences may also be introduced into
Caulobacter on a plasmid that is not replicated by
Caulobacter. At a low but practicable frequency,
homologous recombination of the incoming modified S-layer
gene with the chromosome-resident copy of the S-layer gene
in the cell will result in a gene rescue or transfer event.
In some cases it may be desirable to obtain a stable cell
line in which the chimeric S-layer gene is chromosomal.
Various protocols for creating chromosomal insertions are
set out in the Examples.
Use of the S-layer protein as a vehicle for production
of a heterologous polypeptide has several advantages.
Firstly, the S-layer protein is synthesized in large
quantities and has a generally repetitive sequence. This
permits the development of systems for synthesis of a
relatively large amount of heterologous material as a
fusion product with an S-layer protein (chimeric protein).
It may be desirable to retain the chimeric protein as part
of the bacterial cell envelope or, the fusion product may
be separated from the organism, such as by the method
described in: Walker, S.G., et al. 1992. "Isolation and
Comparison of the Paracrystalline Surface Layer Proteins of
Freshwater Caulobacters". J. Bacteriol. 174:1783-1792.
Alternatively, the Caulobacter strain that is used to
express the fusion product may be derived from a strain
such as CB15Ca5 that sheds its S-layer.
This invention is particularly suited for use in a
bioreactor systems. An example would be the use of a
CA 02261186 1999-02-19
- 19 -
modified Caulobacter to treat sewage, waste water etc.
Caulobacters are ideal candidates for fixed-cell
bioreactors, the construction of which is well known. An
example of such a bioreactor is a rotating biological
contactor. Although other bacteria are found in the
environment, they often produce copious polysaccharide
slimes that quickly plug filtration systems. In some
cases, the bacteria are not surface-adherent or the
bacteria do not show selectivity towards key toxic metals.
By taking advantage of the natural bio-film forming
characteristics of Caulobacter, bioreactors may be formed
comprising a substrate and a single layer of cells adhered
thereon, with the cells distributed at high density. A
variety of substrates may be used such as a column of
chemically derivatized glass beads or a porous ceramic
material such as ceramic foam.
Another advantageous application for this invention is
in the production of batch cultures of modified Caulobacter
wherein the S-layer protein is a fusion product with an
enzyme. For example, such Caulobacter could be grown in
wood pulp suspensions at an appropriate juncture of the
pulping process in order to provide for enzymatic
decomposition of the wood-pulp structure.
Examples of enzymes that may be expressed as chimeric
S-layer proteins include alkaline phosphatase (eg. by
expression of the pho A gene of E. coli; see: Hoffman,
C.S., and Wright, A. 1985. "Fusions of Secreted Protein to
Alkaline Phosphatase: An Approach for Studying Protein
Secretion". Proc. Natl. Acad. Sci. U.S.A. 82:5107-5111;
Bingle, W.H., et al. 1993." An "All Purpose" Cellulase
Reporter for Gene Fusion Studies and Application to the
Paracrystalline Surface (S)-Layer Protein of Caulobacter
crescentus". Can. J. Microbio1.39: 70-80; and Bingle, W.H.
and Smit, J. 1994. "Alkaline Phosphatase and a Cellulase
Reporter Protein Are Not Exported From the Cytoplasm When
CA 02261186 1999-02-19
- 20 -
Fused to Large N-terminal Portions of the Caulobacter
crescentus Surface (S)-Layer Protein". Can. J. Microbiol.
40:777-782.) and, cellulase (eg. by expression of the CenA
gene of Cellulomonas fimi; see: Bingle, W.H. et al. (1993)
[su ra]; and Bingle, W.H. and Smit, J. (1994) [supra]).
Another advantageous application of this invention is
the production of organisms that secrete and optionally
present vaccine-candidate epitopes. For example, modified
Caulobacter may be readily cultured in outdoor freshwater
environments and would be particularly useful in fish
vaccines. The two-dimensional crystalline array of the
S-protein layer of Caulobacter, which has a geometrically
regular, repetitive structure, provides an ideal means for
dense packing and presentation of a foreign epitope to an
immune system in cases where the epitope is part of an
intact S-layer in the bacterial cell surface.
This invention also provides an efficient expression
system for polypeptides that may be harvested in large
quantities relatively free of contaminants and protein of
Caulobacter origin. Expression of a heterologous
polypeptide fused with sufficient C-terminal amino acids of
the S-layer protein to promote secretion of the
heterologous polypeptide results in the accumulation of
large quantities of secreted protein in the cell medium.
The chimeric protein does not have to be released from the
cell surface, but adjustment of the size of the S-layer
protein portion can dictate whether the secreted chimeric
protein is soluble or will precipitate in the cell medium.
This embodiment may also be useful in cases where the
Caulobacter is to express a foreign antigenic component and
it is desired to minimize the amount of Caulobacter protein
that is associated with the foreign antigen secreted by the
Caulobacter.
CA 02261186 1999-02-19
- 21 -
Example 1: Production of
Permissive Insertion Sites in C.crescentus
Using the restriction enzyme Ta~I, a partial digestion
of the rsaA gene in pTZl8U:rsaA~P produced a group of
linearized segments with random TaaI sites cleaved. The
linearized segments were modified by use of the tagged
linker mutagenesis procedure of Bingle and Smit (1991)
[supra] , using the 12-by BamHI linker carried in plasmid
pUC102K discussed in the general procedure above. Those
products that produced a full-length protein in E. coli
were ultimately transferred to pWBI (a minor variation of
pWB9 that is replicated by Caulobacter), as described in
the general procedure. The resulting construction was
introduced into a C. crescentus strain. Distinguishable
events were retrieved and analyzed for the ability to
produce a full-length protein in C. crescentus and to
produce the crystalline S-layer on their surface and the
approximate location of the insertion. Cells were screened
for the presence of a S-layer protein of approximately
100kDa that is extracted from the surface of whole cells by
100 mM HEPES at ph2. The results of this screening
together resulted in five successful events.
The above-described five positive events represent
cases where the 4-amino acid insertion was tolerated with
no effect on the S-layer function. The S-layers of the
modified Caulobacter were indistinguishable from a
wild-type S-layer. Thus, they have a higher potential for
tolerating the addition of more foreign peptide material
than less characterized sites. By producing 3 versions of
the gene of interest, representing each possible reading
frame (using standard linker addition technology), one may
test each of these sites for suitability in expressing the
desired activity. Also, by using restriction enzymes other
than Ta~I (such as AciI, HinPI or MSpI) a larger library of
BamHI insertions may be created.
CA 02261186 1999-02-19
- 22 -
Example 2: Investigation of
Other Permissive Sites in rsaA Gene
A library of 240 BamHI linker insertions was created
using the procedures of Example 1. Of the 240 insertions,
45 target sites in the rsaA gene were made with TagI. 34
of the latter insertions were discarded because the clones
contained deletions of rsaA DNA as well as the linker
insertions. The remaining 11 resulted in 5 non-permissive
and the 5 permissive sites found in Example 1. The
remaining 195 insertions in the library were made using the
enzymes HinPI, AciI, and MSpI to create target sites as
outlined in Example 1. Of the latter 195 insertions, 49
permissive sites were located for a total of 55. Of those
sites scored as non-permissive, some may have had deletions
of rsaA DNA at the linker insertion site. One BamHI linker
insertion at a TaqI site thought to be permissive was later
found by nucleotide sequencing to be located outside the
rsaA structural gene reducing the total number of
permissive sites to 54 from 55. The results show that
sites that will accept 2-4 amino acids while still allowing
the protein to be made and assembled into an S-layer are
scattered up and down the protein. Furthermore, there is
a high proportion of sites at which such insertions do not
prevent expression and assembly of the S-layer.
Approximately 25-500 of in-frame linker insertions will be
tolerated by the S-layer protein and the Caulobacter and
that diverse regions of the protein will tolerate
insertions. Thus, Caulobacter is an ideal candidate for
expression of polypeptides fused with the S-layer and the
presence of multiple permissive sites extending along the
rsaA gene will permit the insertion of a plurality of the
same or different peptides into the same RsaA protein
molecule and expressed on the surface of a single
Caulobacter.
CA 02261186 1999-02-19
- 23 -
Example 3: Studies with Cadmium Binding Polypeptides
Consideration of the predicted amino acid sequence of
the C. crescentus protein shows that the latter protein
lacks cysteine residues. Following the foregoing
procedures, single and multiple copies of DNA encoding a
synthetic cadmium binding peptide were synthesized,
inserted at the amino acid 277 site of rsaA using the above
described Carrier cassette, and expressed in C. crescentus.
The peptide has a single cysteine residue. Mild acid
extracts of whole cells expressing the modified gene were
subjected to SDS-PAGE for identification of S-layer
proteins. The S-layer protein was expressed and secreted
when there was from 1 to 3 copies of the cadmium binding
peptide present at RsaA amino acid position 277. Insertion
of 4 or more copies resulted in a dramatic reduction of
S-layer protein released from the whole cells by mild acid
treatment to barely detectable levels. Detection by
autoradiography of RsaA protein in vivo labelled with 35
S-cysteine and in vitro with 125 I-iodoacetamide confirmed
that the cadmium binding peptide was part of the chimeric
RsaA protein. This demonstrates that Caulobacter
crescentus is capable of secretion of a chimeric rsaA
protein having a limited cysteine content and a limited
capacity for disulphide bond formation within the chimeric
protein but that increased capacity of disulphide bond
formation will limit production.
Example 4: Expression and Presentation
of Antigenic Epitopes on Caulobacter Cell Surface
Using the library of the 49 permissive sites other
than those made with TaaI described in Example 2, the
coding sequence for a 12-amino acid pilus peptide epitope
lacking cysteine residues from Pseudomonas aeruginosa PAK
pilus (described in Figure 8 of WO 97/34000) was inserted
at the sites using the procedures described above and
CA 02261186 1999-02-19
- 24 -
employing the Carrier cassette described above.
Positioning of the added DNA between the first Bam HI site
and the Bal II site permitted use of the latter site for
making repeated insertions of DNA.
DNA coding for the PAK pilus peptide was prepared by
oligonucleotide synthesis of two anti-complementary
strands. The transformed bacteria were screened for both
production and presentation of the epitopes by the
transformed Caulobacter by using standard Western
immunoblot analysis (see: Burnette, W. N. 1981. "Western
Blotting; Electrophoretic Transfer of Protein from Sodium
Dodecyl-Polyacrylamide Gels to Unmodified Nitrocellulose
and Radiographic Detection Antibody and Radioiodinated
Protein A". Analytical Biochemistry 112:195-203) and by
colony immunoblot tests in which the cells were not
disrupted (see: Engleberg, N.C., et al. 1984. "Cloning an
Expression of Legionella pneumophilia Antigens in
Escherichia coli". Infection and Immunity 44:222-227).
Anti-pilus monoclonal antibody obtained from Dr. Irvin,
Dept. of Microbiology, University of Alberta (Canada) was
used in the immunoblot analyses to detect the presence of
the pilus epitope insert. The antibody (called PK99H) was
prepared using purified Pseudomonas aeruginosa PAK pilus as
the antigen and the monoclonal antibody against the 12
amino acid epitope was isolated by standard techniques
using BALB/C mice as a source of ascites fluid. Reaction
with the antibody in the whole cell colony immunoblot assay
shows that the epitope is not only expressed in the
transformed Caulobacter but is exposed on the S-layer
surface overlying the cell in such a way that the epitope
is available to the antibody. When the two cysteine
residues of the pilin epitope were incorporated in the
chimeric protein, the protein was still expressed and
secreted at normal levels.
CA 02261186 1999-02-19
- 25 -
Of the organisms screened, insertions of the pilus
epitope at the following sites in the rsaA gene as
determined by nucleotide sequencing resulted in a positive
reaction with the antibody in the whole cell Colony
immunoblot analysis: 69, 277, 353, 450, 485, 467, 551, 574,
622, 690, 723, and 944. The results show that the
permissive sites that will accept polypeptides of the size
of the epitope are numerous and scattered across the gene.
Further studies with the pilus peptide resulted in
successful expression and secretion of chimeric proteins
having single copies of the peptide at various other
locations. Also, four and seven copies of the peptide were
expressed and secreted as a RsaA chimeric protein when
inserted at amino acids 277 and 551 respectively of the
RsaA protein. However, insertions of the peptide at amino
acids 69, 277, 450, 551 and 622 resulted in a chimeric
protein that did not attach to the cell surface and was
released into the culture medium.
ExamQle 5: Insertion of Larae Polypeptides
Bacterial surface proteins from organisms other than
Caulobacter described in the prior art are generally not
known to accept polypeptides larger than about 60 amino
acids within the structure of the surface protein. The
procedures of the preceding Example were carried out in
order to insert the coding sequence of a 109 amino acid
epitope from IHNV virus coat glycoprotein at insertion
sites identified in the preceding Example. The IHNV
epitope was prepared by PCR and had a sequence as shown in
Figure 9 of WO 97/34000, which is equivalent to amino acid
residues 336-444 of the IHNV sequence described in:
Koener, J.F. et al. 1987. "Nucleotide Sequence of a cDNA
Clone Carrying the Glycoprotein Gene of Infectious
Hematopoietic Necrosis Virus, a Fish Rhabdovirus". Journal
of Virology 61:1342-1349. Anti-IHNV polyclonal antibody
CA 02261186 1999-02-19
- 26 -
against whole IHNV obtained from Dr. Joann Leong, Dept. of
Microbiology, Oregon State University, U.S.A. (see: Xu, L.
et al. 1991. "Epitope Mapping and Characterization of the
Infectious Hematopoietic Necrosis Virus Glycoprotein, Using
Fusion Proteins Synthesized in Escherichia coli". Journal
of Virology 65:1611-1615) was used in immunoblot assays as
described in the preceding Example to screen for
Caulobacter that express and present the IHNV sequence on
the surface of the S-layer of the Caulobacter. Reaction in
the whole cell colony immunoblot assay was positive in
respect of insertions at sites 450 and 551, and negative at
a site which was at approximately amino acid 585.
The IHNV insert contains a single cysteine residue and
is an extremely large insert for successful expression as
a fusion product with a bacterial surface protein.
In further studies, the same 109 amino acid portion of
the IHNV glycoprotein was inserted at amino acid 450 of the
RsaA protein. The chimeric protein expressed and secreted
by C. crescentus and was recovered from the cell culture
medium. SDS-PAGE analysis of the recovered proteins showed
that some of the chimeric proteins were smaller than the
predicted rsaA chimeric protein but still bound anti-IHNV
antibody. Analysis of these proteolytic products showed
that cleavage of the chimeric protein occurred at an Arg
residue encoded by the gene transfer cassette. Thus in
some cases, adjustment of the nucleotide sequence at the
interface of the polypeptide and rsaA coding sequences may
be necessary to prevent expression of an arginine residue.
Example 6:
Methods are described above for the insertion of 12-by
BamHI linker sites into a promoterless version of the rsaA
gene. Because linker insertions involve the insertion of
12 by (i.e. a multiple of three) an in-frame linker
CA 02261186 1999-02-19
- 27 -
insertion resulted in every case. These linker sites are
introduced to allow subsequent insertion of DNA encoding
foreign peptide/proteins. Expression of such chimeric
genes leads to the production of an entire full-length RsaA
protein carrying the inserted heterologous amino acid
sequence of interest. A number of BamHI site positions
were identified above precisely by nucleotide sequencing.
Four of the sites in the rsaA gene correspond to amino acid
positions 188, 782, 905, 944 in the RsaA protein. For this
example, an additional linker insertion was created at
amino acid position 95 of the native gene (i.e. this gene
carried its own promoter) using the same methodology. All
five in-frame BamHI linker insertion sites were inserted in
the rsaA so that the nucleotides of the linker DNA were
read in the reading frame GGA/TCC.
Because all BamHI linker nucleotides were read in the
same reading frame, the 5' region of one rsaA gene carrying
a BamHI linker insertion at one position could be combined
with the 3' region of an rsaA gene carrying another of the
BamHI linker insertions to create in-frame deletions with
a BamHI site at the joint between adjacent regions of rsaA.
Using such a method, in-frame deletions of rsaA (~AA95-782)
and rsaA(~AA188-782) were created.
DNA fragments encoding various C-terminal portions of
the 1026 amino acid RsaA protein were isolated using the
newly inserted BamHI linker sites as the 5'-terminus of the
fragment and a HindIII site as the 3' terminus of the
fragment . These BamHI fragments were transferred to the
BamHI/HindIII sites of pUC8 (J. Vieira, and J. Messing.
1982." The pUC Plasmids, an M13mp7-Derived System for
Insertion Mutagenesis and Sequencing With Synthetic
Universal Primers" Gene 19:259-268) creating "rsaA
C-terminal Segment Carrier plasmids" (see Figure 12 of
WO 97/34000). The insertion into pUC8 also resulted in the
creation of an in-frame fusion between the first 10 N-
CA 02261186 1999-02-19
- 28 -
terminal amino acids of LacZa and the various C-terminal
fragments (AA782-1026, AA905-1026 or AA944-1026) of RsaA.
These LacZa:rsaA fusion proteins can be produced in
C. crescentus using the lacZa transcription/translation
initiation signals when introduced on appropriate plasmid
vectors or direct insertion into the chromosome (see: W.H.
Bingle, et al. 1993. "An All-Purpose Cellulase Reporter for
Gene Fusion Studies and Application to the Paracrystalline
Surface (S)-Layer Protein of Caulobacter crescentus."
Can. J. Microbiol. 39:70-80).
Both types of constructions (i.e., the deletion
versions and the C-terminal only segments) result in the
production of proteins that are secreted in Caulobacter
strains as highly modified S-layer proteins. The gene
segments can also facilitate the secretion of heterologous
polypeptides by insertion or fusion of appropriate DNA
sequences at the unique BamH1 site that exists in each of
the constructions. The following describes specific
methods for doing so to create chimeric proteins capable of
secretion in Caulobacter.
A- Creating Fusions of Desired Sequences with C-terminal
Portions of a Caulobacter S-layer Gene -Method 1
The general process is as follows:
(1) Inserting the desired sequence into the Carrier
cassette. The following describes the specific manner in
which heterologous sequences may be introduced into a
Carrier cassette as described above.
(a) Insertion of a single copy of the desired gene
segment.
Depending upon the length of the gene segment, two
methods of construction may be used. For segments of up to
CA 02261186 1999-02-19
- 29 -
about 30 amino acids, two oligonucleotides of appropriate
sequence are chemically synthesized, annealed by mixing,
heating and slow cooling and then ligated into the Carrier
cassette. The oligonucleotides will also contain
additional base pairs that recreate "sticky ends" of
appropriate restriction endonuclease sites at each end of
the duplex DNA that results from the annealing process.
For longer segments, PCR is used to amplify a region
of a target DNA sequence. Oligonucleotides are synthesized
that have sequence complementary to the boundaries of the
desired sequence and which contain additional base pairs
that recreate a "sticky end" of an appropriate restriction
endonuclease site. In the present example oligonucleotides
are made to produce products with the appropriate
restriction endonuclease site for directional cloning into
the Carrier cassette. PCR amplification of the desired
sequence is then done by standard methods.
For both methods, the sticky ends prepared must be
appropriate for restriction sites at the 5' terminus and
the 3' terminus. This places the desired gene segment in
the correct orientation within the Carrier cassette.
Reading frame continuity is maintained by appropriate
design of the oligonucleotides used for the PCR step.
(b) Preparation of multiple copies of the desired gene
segment.
The Carrier cassette also allows production of
multiple insert copies. For example, a restriction site in
the cassette may be restored after removal of a
promoterless antibiotic resistance gene and that site is
then used to insert an additional copy of the
Carrier/desired sequence insertion, as described in
WO 97/34000. This "piggy-back" insertion still maintains
the correct reading frame throughout the construction. Any
CA 02261186 1999-02-19
- 30 -
number of additional cycles of "piggy-backing" can be done
because the ligation results in a sequence which is no
longer a substrate for the restriction enzymes used. The
result is the production of cassettes of multiple copies of
the desired sequence which can be transferred to
appropriately modified S-layer protein genes with the same
ease as a single copy. An additional feature of this
method is that different heterologous sequences can be
paired together in this multiple copy cassette with the
same ease as multiple copies of the same heterologous
sequence.
Example 6a: Insertion of an 109 amino acid segment of the
IHNV surface glycoprotein to Carrier cassette.
Using the methods described, a PCR product was made
that contained the DNA coding for amino acids 336 to 444 of
the major surface glycoprotein of the Infectious
Hematopoietic Necrosis Virus (IHNV), as described in
WO 97/34000.
Example 6b: Insertion of an 184 amino acid segment of the
IHNV surface glycoprotein to Carrier cassette.
Using the methods described a PCR product was made
that contained the DNA coding for amino acids 270 to 453 of
the IHNV glycoprotein segment.
Example 6c: Insertion of single and multiple copies and an
epitope of the Pseudomonas aeruginosa PAK pilus gene to
Carrier cassette.
Oligonucleotides were constructed to code for the
pilus epitope described in Example 4, which corresponds to
a sequence at the extreme C-terminus of the pilus protein.
Using the methods outlined in part A(1)(b) of this Example,
3 tandem copies were prepared.
CA 02261186 1999-02-19
- 31 -
(2) Transfer of Carrier cassette to the a C-terminal
Segment Carrier plasmids. The constructions described in
Examples 6a and 6b above were transferred to rsaA
C-terminal Segment Carrier plasmids, as described above,
resulting in an in-frame fusion of: a) a very short
section of the betagalactosidase protein (10 amino acids),
(b) the desired sequence flanked by 2-3 amino acids derived
from Carrier cassette sequence, and (c) the appropriate
rsaA C-terminal segment. In some cases, the first codon of
the rsaA C-terminal segment is converted to a different
codon as a result of the fusion. For example, while the
rsaA C-terminal segment may have coded for amino acids
944-1026 of RsaA, the resulting chimeric protein may only
have amino acids 945-1026 native to RsaA.
Example 6d: Fusion of Carrier/109 AA and 184 IHNV segments
to C-terminal rsaA segment AA782-1026.
This was done using the Carrier cassettes described in
Examples 6a and 6b above and the AA782-1026 rsaA C-terminal
Segment Carrier plasmid described above.
Example 6e: Fusion of Carrier/109 AA and 184 AA IHNV
segments to C-terminal rsaA segment AA905-1026.
This was done using the Carrier cassettes described in
Examples 6a and 6b above and the AA905-1026 rsaA C-terminal
Segment Carrier plasmid described above.
Example 6f: Fusion of Carrier/109 AA and 184 AA IHNV
segments to C-terminal rsaA segment AA944-1026.
This was done using the Carrier cassettes described in
Examples 6a and 6b above and the AA944-1026 rsaA C-terminal
Segment Carrier plasmid described above.
CA 02261186 1999-02-19
- 32 -
Example 6a: Fusion of Carrier/3x Pilus Epitope segment to
C-terminal rsaA segment AA782-1026.
This was done using the Carrier cassettes described in
Example 6c above and the AA782-1026 rsaA C-terminal Segment
Carrier plasmid described above.
(3) Expression of the Desired Fusion
in an Appropriate Caulobacter Host Strain.
(a) Plasmid-based expression.
To create plasmid vectors that can be introduced and
maintained in Caulobacter, an entire C-terminal Segment
Carrier plasmid may be fused to a broad host range vector
such as pKT215 or pKT210 (see: M. Bagdasarian, et al.
1981." Specific-Purpose Cloning Vectors. II.
Broad-Host-Range, High Copy Number RSF1010-Derived Vectors,
and a Host-Vector System for Gene Cloning in Pseudomonas."
Gene 16:237-247) using the unique HindIII restriction site
present in each plasmid. The resulting plasmid is
introduced into Caulobacter by conjugation or
electroporation methods and is maintained by appropriate
antibiotic selection.
The fusions described in Examples 6d-6g were expressed
in Caulobacter. In each case expression and secretion of
the chimeric S-layer protein was detected by Western
immunoblot analysis of electrophoretic gels of the cell
culture supermutant employing the monoclonal antibody for
each of the polypeptide epitopes. The transporter signal
for secretion from Caulobacter must be in the C-terminal
region of amino acids 945-1026 of the S-layer protein as
all chimeric proteins in the Examples were secreted.
Precipitation of the chimeric protein occurred with the use
of rsaA segment AA782-1026 but not AA944-1026. Recovery of
CA 02261186 1999-02-19
- 33 -
precipitate using AA905-1026 was reduced as compared to
AA782-1026.
(b) Selection of appropriate Caulobacter host strains.
In nearly all cases the use of a S-layer negative host
strain is appropriate. In C. crescentus, strains CB2A and
strain CBI5aKSac fulfil this requirement. If it is
important to ensure that all fusion protein is no longer
attached to the cell surface, the use C. crescentus strains
CB15Ca5KSac or CBl5CalOKSac are appropriate. These strains
have additional mutations that result in the loss of the
production of a specific species of surface
lipopolysaccharide that has been demonstrated to be
involved with the surface attachment of native S-layer
protein as a 2-dimensional crystalline array (see: Walker
S.G. et al. 1994. "Characterization of Mutants of
C. crescentus Defective in Surface Attachment of the
Paracrystalline Surface Layer". J. Bacteriol.
176:6312-6323). Most often with the highly modified
versions of the S-layer gene, this precaution is not
necessary since virtually all regions of the gene that may
have a role in the attachment process have been removed.
An example of a growth media well suited to both
propagation of Caulobacter for general purposes (including
cloning steps) and also to produce the secreted and
aggregated chimeric proteins is PYE medium, a peptone and
yeast extract based medium described in Walker et al.,
(1994) [supra .
B- Creating Fusions of Desired
Sequences with C-terminal Portions -Method 2
Methods other than the use of the Carrier cassette
plasmids are possible to create heterologous insertions
into deletion versions of a S-layer gene or to create
CA 02261186 1999-02-19
- 34 -
fusions with C-terminal portions of the S-layer protein.
PCR may be used although other known methods may also be
used. The general procedure is as follows:
(1) Use PCR to prepare appropriate segments:
(a) Preparation of amplified segment with appropriate
ends may be carried out in a manner similar to that
described part A(1)(a) above. Oligonucleotides are
designed and synthesized such that they will anneal to
appropriate regions of the desired heterologous DNA and
also contain "sticky ends" of appropriate sequence and
frame so that the resulting PCR product can be directly
inserted into appropriate modified S-layer genes.
(b) Transfer to appropriate C-terminal segments is
carried out by inserting the PCR products into selected
C-terminal segments such as AA782-1026, AA905-1026, or
AA944-1026, as described in Examples 6d-6g above. In
addition to the BamHI site described, the EcoR1 restriction
site could also be used as the 5' terminus of the incoming
PCR segment, since this site is also available in the pUC8
vector and not in the S-layer gene, so long as the correct
reading frame was maintained when designing the
ol:igonucleotides used to prepare the PCR product.
(2) Expression of the desired fusion in an appropriate
Caulobacter host strain is carried out using the procedures
outlined in part A(3) above.
C- Creating Insertions of Desired Sequences into Versions
of a S-layer Gene Having Large Internal In-frame Deletions.
The general process is as follows, with reference to
rsaA:
CA 02261186 1999-02-19
- 35 -
(1) Creating' Appropriate In-frame Deletions
rsaA (~AA95-782) and rsaA(~AA188-782) were prepared as
described above. Because most of the BamHl linker
insertion sites are in the same reading frame with respect
to each other, it is possible to combine other pairs of 5'
and 3' segments using the same general method, with the
same result of maintenance of correct reading frame
throughout. These deletion versions must then be tested
individually to ensure that S-layer protein is still
secreted by the Caulobacter.
(2) Insertion of a Gene Segment Carrier Cassette Containing
the Desired Sequences: insertion and transfer of Carrier
cassettes was done using the procedures described in parts
A ( 1 ) and A ( 2 ) above .
Example 6h: Insertion of the 109 AA IHNV segment into rsaA
(~AA95-782) and insertion of the 109 AA IHNV segment into
rsaA(~AA188-782) is carried out as in Examples 7d-7g above.
Expression of the desired genetic construction in
appropriate C. crescentus strains is done using the
procedures outlined in part A(3) above.
(3) Alternate PCR Procedures: can be used to prepare a
heterologous segment for direct insertion into the BamHI
site with the deletion versions of the rsaA gene. The
procedure is essentially the same as described in part B(1)
above.
CA 02261186 1999-02-19
- 36 -
Example 7: Transfer to the Native S-layer
Gene Chromosomal Site as a Single Crossover Event
Fusion of a Carrier cassette with appropriate
heterologous DNA segments to a C-terminal S-layer protein
segment plasmid results in a plasmid that is not maintained
in Caulobacter. Selection for the antibiotic marker on the
plasmid results in detection of the rescue events. Most
commonly these are single crossover homologous
recombination events. The result is a direct insertion of
the entire plasmid into the chromosome. Thus the resident
copy of the S-layer gene remains unchanged as well as the
incoming highly modified S-layer gene. In such cases it
may be desirable to use Caulobacter strains in which the
resident S-layer gene is inactivated in known ways. One
example is the use of C. crescentus strain CB15AKSac; this
strain has an antibiotic resistance gene cassette
introduced at a position in the S-layer gene about 250 of
the way from the 5' terminus.
Example 8: Transfer to the Native S-layer
Gene Chromosomal Site as a Double Crossover Event
In certain cases it may be desirable to completely
exchange the resident S-layer gene copy with the incoming
highly modified version. One method is the incorporation
of a sacB gene cassette (Hynes, M.F., et al. 1989. "Direct
Selection for Curing and Deletion of Rhizobium Plasmids
Using Transposons Carrying the Bacillus subtilis sacB
Gene." Gene 78: 111-119) into the pUC8 based plasmids
carrying the desired chimeric gene construction. This
cassette contains a levansucrase gene from Bacillus
subtilis that, in the presence of sucrose, is thought to
result in the production of a sugar polymer that is toxic
to most bacteria when expressed inside the cell. One first
selects for the single crossover event as described in
Example 7. Subsequent growth on sucrose-containing medium
CA 02261186 1999-02-19
- 37 -
results in the death of all cells except those that lose
the offending sacB gene by homologous recombination within
the 2 adjacent gene copies. Two events are possible;
restoration of the resident copy of the S-layer gene or
replacement of the resident copy with the incoming modified
gene (the latter is the desired event). A screen with
insertion DNA as probe or antibody specific to the
heterologous gene product identifies successful gene
replacement events. The method requires that the S-layer
gene sequence or native sequence immediately adjacent to
the S-layer gene be on both sides of the heterologous
sequence (i.e., Carrier cassette sequence plus heterologous
DNA) and in the present case is best suited for the
deletion versions of the S-layer gene.
Other methods are available for the delivery of
genes to the chromosome of a Caulobacter. Methods
involving the use of the transposons Tn5 and Tn7 as a means
of delivery of genes to random chromosome locations are
available (see: Barry, G.F. 1988 "A Broad-Host-Range
Shuttle System for Gene Insertion into the Chromosomes of
Gram-Negative Bacteria." Gene 71:75-84.). The use of the
xylose utilization operon as a target for chromosome
insertion have also been described. This method involves
the incorporation of a portion that operon into the pUC8
based plasmid constructions described above. This allows
homologous recombination within the xylose operon as a
means of plasmid rescue. Loss of the ability to use xylose
as a nutrition source is used as the means of confirming
the rescue event.
Example 9: Transformation and Expression of Heteroloaous
Protein in Caulobacter other than C. crescentus
Using the procedures described above, a DNA construct
made according to Examples 4 and 6 was introduced into the
freshwater S-layer producing Caulobacter strain identified
CA 02261186 1999-02-19
- 38 -
as FWC42 in MacRae, J.D. and J. Smit (1991) and in Walker,
S.G. et al. (1992) [su ra]. FCW42 is clearly distinct as
a species from C. crescentus. The construct contained 3
copies of the pilus epitope as the heterologous polypeptide
and a nucleotide sequence encoding amino acids 690-1026 of
RsaA as the secretion signal. The heterologous polypeptide
was expressed by the transformed FCW42 cells and was
secreted at sufficient levels such that the secreted
protein was found in the cell medium as an aggregate.
Example 10: Demonstration of Type I
Secretion Mechanism in Various Caulobacter
The following non-C. crescentus species of Caulobacter
as described in MacRae, J.D. and J. Smit (1991) and in
Walker, S.G. et al. (1992) [supra] were employed in this
Example: FWC8, FWC9, FWC17 and FWC19, FWC28, FWC32, FWC39
and FWC42. Employing the materials and methods described
in Awram, P. and J. Smit (1998) "The Caulobacter crescentus
Paracrystalline S-layer Protein as Secreted by an ABC
Transporter (Type I) Secretion Apparatus", J. of
Bacteriology 180:3062-3069, the aforementioned strains were
transfected with plasmids containing the alkaline protease
gene. The protease was shown to be secreted at levels
comparable to the levels of such protease reported by Awran
and Smit for C. crescentus strains that were transformed in
the same way. Thus, the transport mechanism in the
non-C. crescentus strains is a Type I mechanism recognizing
C-terminal secretion signals.
Example 11: Sequence Similarity S-layer
Genes and Downstream Transporter Genes
The Table below sets out results of sequencing of S-
layer related genes in 2 strains of C. crescentus (NA1000
and CB2) and four non-C. crescentus species of S-layer
producing freshwater Caulobacter. Genes identified as A,
CA 02261186 1999-02-19
- 39 -
D and E are the S-layer structural gene and the immediate
two downstream transporter genes, respectively. The
transport mechanism, including the C-terminal region of the
structural gene (secretion signal region) are highly
conserved. A region of the S-layer gene in FWC27 outside
the C-terminal shows clear divergence from the equivalent
region in the two C. crescentus strains.
CA 02261186 1999-02-19
- 40 -
N
'~
- o ~N z z ~~ z z
;
~~ d1 00 U
M M
~h ~ M
d"
U
cn
4.
O
_ p p M
_ M M
~
'.r~ M~ L~ Ca b~~ Gl L Ow.
-~$M aM z z ~ z z
ch' M V1 ~,
M .-.
~
, v;
b
~
_
~
v:
m V
b c3
~n ~1 O U O
~
ch ~ _ ~ c~ C
~ ~ ~
'~i'
__,w OA
w ~ ~ ~
O~
Wit'
~'~ Ov - N ~ ~ ~ Ov
v7 V~ ~
V7 ~ ~Y ~ M ~ Q'
N V
U w
i i
C V
N
V~
y o, ~, , , ~.
,
~ ~ ~, z
V~ V1 M M M M
V O C CJ
U
C
m '
d
~ ~ ~
~
N N o0
O ~ p v; ~ r
O a1
b ~' V7
y ~ o O
,.r ,~ ~ cC
N N
O O ~ ~ ~ ~ b~ b~ ~ b~
y ~ .~ O r- -- V
~
O 00 00 f
00
O
~ ~ v~ 'wi ~ tn V7 V~
N
v
V
l~ V. d.
O O
- v0 v0 ~
N N ~,
~
V O
Vi
o0 V
b~ 6~ ~ ~ 00
~ V7 O V7
a M ~ ~' oo ~t
I ~ G~ G1 b D ~
$~ ~ z ~~ J: l '/: V: J: ;/; ;/;
~ ~z
v . z z z
,~ ,..i
f N ~
J U
U
V
V
J
U
O O ~ ~
c
3 c
~ c~
~3 c
3 ~ c
3 .~
~
;n
O O O O O O O O
C_ G_ C_ ~_ C_ C_ C_ .
U
a
n c~ n n n c~ o
~C ~ ~C .~C .~ .~C '/:
L
O ~ N 00 V'~ M ~ :'3 O N 'D 00 ~ M
o N o ~r o~ ~
o:~
~~3 m3333
~
c f
~ ~ U Ci, U Gz. ti, fj.~
ti.
y ~ ~ Q
~U ~ ~ ~ O
U U O
o ~. ~ ~. w~
z
N M
'
U ~ N U U U U U ~-
~
o~ o
t3z U w ~ ~ ~
~
~ ~
Q
_
N
z
CA 02261186 1999-02-19
- 41 -
This invention now being described, it will be
apparent to one of ordinary skill in the art that changes
and modifications can be made thereto without departing
from the spirit or scope of the appended claims.
